在骨科运动外科手术临床试验的首席研究员中女性代表的趋势
Rayyan Abid1,2, Robert J Burkhart1,3, GianMarco Douglas1
1University Hospitals Drusinsky Sports Medicine Institute, Cleveland, Ohio, USA.
Orthopaedic journal of sports medicine
|December 15, 2025
概括
妇女领导的骨科运动医学临床试验只有17%,随着时间的推移没有显著增加. 然而,女性在试验领导层中可能比她们在实地存在的比例过高.
科学领域:
- 整形外科手术 整形外科手术
- 运动医学运动医学
- 临床试验中的临床试验.
- 性别差异性差异性差异性差异性差异性差异性差异性
背景情况:
- 妇女在学术骨科,作者和奖项中代表性不足.
- 这项研究调查了骨科体育医学临床试验领导的性别差异.
研究的目的:
- 确定女性在骨科体育医学临床试验中担任首席研究员 (PI) 的代表人数不足程度.
- 分析随着时间的推移女性代表的趋势,并将其与她们在现场的代表性进行比较.
主要方法:
- 一个横截面研究,分析来自clinicaltrials.gov (2005-2025) 的数据.
- 确定了整形体育手术试验,并记录了PI的性别,试验特征和地理分布.
- 使用奇平方测试和逻辑回归来评估关联和趋势;计算了表示率.
主要成果:
- 在分析的试验中,女性领导了17% (64/377).
- 从2005年到2025年,没有观察到女性PI的显著增加 (P = .11).
- 女性PI显著与世界地区相关 (P < .001),北美代表性最低 (10.6%). 涉及程序的试验 (27.2%) 的代表性更高.
结论:
- 只有很小一部分的骨科运动医学临床试验是由女性领导的.
- 妇女在临床试验领导角色中可能比她们在整体骨科体育医学中的总体代表过多.
更多相关视频
04:41Treatment with Locking Intramedullary Nailing for Intertrochanteric Fracture of the Femur Utilizing a New Awl with a Distal Positioner
Published on: June 6, 2025
797
06:28Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation
Published on: December 13, 2024
1.1K
相关概念视频
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
